Denali Therapeutics Down After Proposing To Sell $250 Million Of Shares

On:

Shares of Denali Therapeutics Inc. (DNLI) are falling more than 9% Wednesday morning at $29.60.

The company today said it proposes offer for sale of $250 million of shares.

DNLI has traded in the range of $20.24-$56.08
in the last 52 weeks.

Source: Read Full Article

Lates News:
  1. Myers Industries Shares Tanks In Spite Of Improved Quarterly Results
  2. Bitcoin Could Have Found Its Bottom At $20,000 Level: Glassnode Report
  3. Affirm Shares Ascend Following Deal With Walmart
  4. This Bitcoiner Just Paid a Whopping $500,000 In Transaction Fees for A 0.074 BTC Transfer
  5. Eos Energy Soars On $500 Mln Plan To Increase Production